![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0087.jpg)
Burkholderia mallei/pseudomallei
$'' !
' +'' $# $%
Bacillus anthracis
Inclusivity Panel – Tier 1
A4.1.1
Bacillus anthracis.
If any listed strain is not available, an alternate strain shall be selected
from the same VNTR group. If an alternate strain from the same VNTR group is not available, a
strain from the same genotype shall be selected. If an alternate strain from the same genotype is not
available, a strain different than those listed below shall be selected if available;
Tier 1
Bacillus anthracis
Inclusivity Panel
Species
Strain
Notes
Bacillus anthracis
Ames
pXO1+, pXO2+; VNTR group A3b; genotype 62
Bacillus anthracis
BA1035
pXO1+, pXO2+, VNTR group B1; genotype 82
Bacillus anthracis
BA0018
pXO1+, pXO2+; VNTR group A1a; genotype 7
Bacillus anthracis
K3
pXO1+, pXO2+; VNTR group A3c; genotype 67
Bacillus anthracis
Ohio ACB
pXO1+, pXO2+; VNTR group A3d; genotype 68
Bacillus anthracis
PAK-1
pXO1+, pXO2+; VNTR group A2; genotype 29
Bacillus anthracis
A
Pasteur
pXO1-, pXO2+; VNTR group A1a; genotype 8
Bacillus anthracis
RA3
pXO1+, pXO2+; VNTR group B2; genotype 80
Bacillus anthracis
SK-102
pXO1+, pXO2+; VNTR group A4; genotype 69
Bacillus anthracis
B
Sterne
pXO1+, pXO2-; VNTR group A3b; genotype 59, 61
Bacillus anthracis
Turkey 32
pXO1+, pXO2+; VNTR group A1b; genotype 23
Bacillus anthracis
B
V770-NP-1R
pXO1+, pXO2-; VNTR group A3A; genotype 45
Bacillus anthracis
Vollum 1B
pXO1+, pXO2+; VNTR group A4; genotype 77
Adapted from Official Methods of Analysis of AOAC INTERNATIONAL (2016) 20th Ed., AOAC INTERNATIONAL, Rockville, MD,
USA, AOAC SMPR 2010.003,
www.eoma.aoac.org,and
Bacillus anthracis
2016.006 - Journal of AOAC International, Volume 99, Number
4, July-August 2016, pp. 1084-1089.
https://doi.org/10.5740/jaoacint.SMPR2016.006.A
This strain should not be included in the inclusivity panel if the product being tested only utilizes a pXO1 assay, as this strain is expected to
be pXO1 negative.
B
These two strains should not be included in the inclusivity panel if the product being tested only utilizes a pXO2 assay, as these strains are
expected to be pXO2 negative.